ArticleInflammopharmacology2026
Bone and growth safety profiles of biologic and conventional DMARDs in juvenile idiopathic arthritis: a 21-year FAERS disproportionality analysis.
Fatih Erdem et al.PubMed ↗Publisher ↗
No numbers read from the abstract.